Nigel Garrard
Bachelor of Economics (Adelaide), CA (Chartered Accountant)
Chairman and Independent Non-Executive Director
Nigel Garrard has over 20 years’ experience as an ASX-listed CEO. As CEO of Orora Ltd., he led the demerger of Orora from Amcor and listing of Orora on ASX. He was President of the Amcor Australasia and Packaging Distribution business group, Managing Director of Coca-Cola Amatil’s Food and Services Division, and Managing Director of SPC Ardmona. Nigel is currently a non-executive director of Ansell Limited and CSR Ltd., and Chairman of Flinders Port Holdings Pty. Ltd. and the McMahon Services advisory board.
Malcolm Deane
Master of Laws, Juris Doctor
Chief Executive Officer and Managing Director
Newly appointed as CEO and Managing Director for ALS Limited, Malcolm Deane has served the company in various executive positions for the past 10 years in such roles as GM for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions. Malcolm has a Master of Laws from the University of Virginia School of Law and Juris Doctor from Universidad Austral – Buenos Aires, Argentina.
John Mulcahy
PhD, B E (Civil Eng) (Hons), FIE Aust
Independent Non-Executive Director
John Mulcahy was appointed a Non-Executive Director of the Company in 2012. He is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries.
Tonianne Dwyer
B Juris (Hons), LLB (Hons), GAICD
Independent Non-Executive Director
Tonianne Dwyer was appointed a Non-Executive Director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets.
Siddhartha Kadia
Ph.D. Biomedical Engineering, B.E., Electronics and Telecommunication
Independent Non-Executive Director
Siddhartha Kadia was appointed a Non-Executive Director of the Company in January 2019. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has a PhD in Biomedical Engineering from Johns Hopkins School of Medicine. Siddhartha has lived and worked in the US, Japan, China and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors.
Leslie Desjardins
B. Industrial Admin, Finance (Kettering), MS. Management (MIT)
Independent Non-Executive Director
Leslie Desjardins was appointed a Non-Executive Director of the Company on 21 November 2019. She has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. Ms Desjardins is currently a Director, Audit Committee Chair, CSR/Risk Committee member with Ansell Limited and Director and Audit Committee Chair with Terry Fox Foundation, Canada.
Peter Possemiers
B ASc., Chemistry/Microbiology, University of South Australia
Independent Non-Executive Director
Peter Possemiers has been named independent Non-Executive Director, effective November 1st, 2022. A 40-year veteran of the TIC sector, he held multiple executive leadership roles for SGS, most notably in global Environment Health and Safety, a CHF $550 million business. As Executive Vice President there, he was a member of their Operations Council with responsibility for growth and profitability, steering 15 strategic acquisitions. Mr. Possemiers is a respected leader with a deep understanding of TIC practices across multiple regions. His M&A track record and network relationships will provide invaluable insight and benefits for ALS Limited.
Erica Mann
Dip. Analytical Chemistry, Marketing Management, Small Business Development
Independent Non-Executive Director
Erica Mann was appointed a Non-Executive Director of the Company on 1 March 2024. She has experience across complex, highly regulated, multi-channel and multi-product environment in top DAX, NYSE, NSDAQ pharmaceutical, OTC and FMCG multinationals. Erica has deep experience with global and emerging markets across Africa, China, Russia and Brazil. She currently holds Non-Executive Director positions on the boards of Kellanova, DSM-Firmenich, and Perrigo.
Search
English
Login
